180 related articles for article (PubMed ID: 33354760)
21. Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma.
Zizzi A; Montironi MA; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Cheng L; Paone N; Castellini P; Montironi R
Diagn Pathol; 2013 Jul; 8():111. PubMed ID: 23819605
[TBL] [Abstract][Full Text] [Related]
22. PD-L1 Antibody Comparison in Urothelial Carcinoma.
Rijnders M; van der Veldt AAM; Zuiverloon TCM; Grünberg K; Thunnissen E; de Wit R; van Leenders GJLH
Eur Urol; 2019 Mar; 75(3):538-540. PubMed ID: 30497882
[No Abstract] [Full Text] [Related]
23. Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
Eltze E; Wild PJ; Wülfing C; Zwarthoff EC; Burger M; Stoehr R; Korsching E; Hartmann A
Eur Urol; 2009 Nov; 56(5):837-45. PubMed ID: 18945538
[TBL] [Abstract][Full Text] [Related]
24. Microtubule-organizing center-mediated structural atypia in low- and high-grade urothelial carcinoma.
Murata SI; Kuroda M; Kawamura N; Warigaya K; Musangile FY; Matsuzaki I; Kojima F
Virchows Arch; 2021 Feb; 478(2):327-334. PubMed ID: 32710188
[TBL] [Abstract][Full Text] [Related]
25. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
Gordetsky J; Epstein JI
Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
[TBL] [Abstract][Full Text] [Related]
26. The prognostic significance of androgen receptor and β-catenin immunohistochemical expression in urothelial carcinoma with and without detrusor muscle invasion from an Egyptian institution.
Elzamy S; Ms AA; Kandeel W
Pol J Pathol; 2018; 69(3):234-242. PubMed ID: 30509050
[TBL] [Abstract][Full Text] [Related]
27. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H
Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878
[TBL] [Abstract][Full Text] [Related]
28. Androgen Receptor Predicts First and Multiple Recurrences in Non-Muscle Invasive Urothelial Carcinoma of the Bladder.
Yonekura S; Terauchi F; Hoshi K; Yamaguchi T; Kawai S
Pathol Oncol Res; 2019 Jul; 25(3):987-994. PubMed ID: 29862474
[TBL] [Abstract][Full Text] [Related]
29. Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence.
Izumi K; Ito Y; Miyamoto H; Miyoshi Y; Ota J; Moriyama M; Murai T; Hayashi H; Inayama Y; Ohashi K; Yao M; Uemura H
Oncotarget; 2016 Mar; 7(12):14153-60. PubMed ID: 26885620
[TBL] [Abstract][Full Text] [Related]
30. MiR-133a-5p inhibits androgen receptor (AR)-induced proliferation in prostate cancer cells via targeting FUsed in Sarcoma (FUS) and AR.
Zheng L; Kang Y; Zhang L; Zou W
Cancer Biol Ther; 2020; 21(1):34-42. PubMed ID: 31736422
[TBL] [Abstract][Full Text] [Related]
31. Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?
Tsai YS; Tzai TS; Chow NH
Urol Int; 2007; 79(3):210-6. PubMed ID: 17940352
[TBL] [Abstract][Full Text] [Related]
32. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.
Boorjian SA; Heemers HV; Frank I; Farmer SA; Schmidt LJ; Sebo TJ; Tindall DJ
Endocr Relat Cancer; 2009 Mar; 16(1):123-37. PubMed ID: 18845648
[TBL] [Abstract][Full Text] [Related]
33. Role of steroid hormone receptors in formation and progression of bladder carcinoma: a case-control study.
Mashhadi R; Pourmand G; Kosari F; Mehrsai A; Salem S; Pourmand MR; Alatab S; Khonsari M; Heydari F; Beladi L; Alizadeh F
Urol J; 2014 Nov; 11(6):1968-73. PubMed ID: 25433476
[TBL] [Abstract][Full Text] [Related]
34. Role of the androgen receptor in urothelial cancer.
Inoue S; Mizushima T; Miyamoto H
Mol Cell Endocrinol; 2018 Apr; 465():73-81. PubMed ID: 28652170
[TBL] [Abstract][Full Text] [Related]
35. Beclin 1 and bcl-2 expressions in bladder urothelial tumors and their association with clinicopathological parameters.
Baspinar S; Bircan S; Yavuz G; Kapucuoglu N
Pathol Res Pract; 2013 Jul; 209(7):418-23. PubMed ID: 23722017
[TBL] [Abstract][Full Text] [Related]
36. Association of epithelial-mesenchymal transition and nuclear cofilin with advanced urothelial cancer.
Hensley PJ; Zetter D; Horbinski CM; Strup SE; Kyprianou N
Hum Pathol; 2016 Nov; 57():68-77. PubMed ID: 27402302
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma.
Eich ML; Tregnago AC; Faraj SF; Palsgrove DN; Fujita K; Bezerra SM; Munari E; Sharma R; Chaux A; Netto GJ
Virchows Arch; 2019 Jan; 474(1):21-27. PubMed ID: 30338346
[TBL] [Abstract][Full Text] [Related]
38. Expression of transcription factor Twist1 in bladder urothelial carcinoma and its clinical significance.
Tang X; Xing J; Li W; Wu Z; Zhang K; Zheng J
J BUON; 2013; 18(1):211-9. PubMed ID: 23613408
[TBL] [Abstract][Full Text] [Related]
39. FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression.
Lloreta J; Font-Tello A; Juanpere N; Frances A; Lorenzo M; Nonell L; de Muga S; Vázquez I; Cecchini L; Hernández-Llodrà S
Hum Pathol; 2017 Apr; 62():222-231. PubMed ID: 28087474
[TBL] [Abstract][Full Text] [Related]
40. Androgen Receptor: Evaluation and Correlation with Recurrence and Clinicopathological Parameters in Papillary Urothelial Carcinomas of the Urinary Bladder.
Mumtaz S; Hussain Z; Janjua TK; Hashmi AA; Qureshi SS; Tariq MU; Faridi N
Cureus; 2020 Jan; 12(1):e6715. PubMed ID: 32104638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]